The Role o f Tetrahydrobiopterin (BH4) Bioavailability in Radiation-induced Skin Injury

四氢生物蝶呤 (BH4) 生物利用度在辐射引起的皮肤损伤中的作用

基本信息

  • 批准号:
    9095913
  • 负责人:
  • 金额:
    $ 26.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Damage to skin tissue caused by ionizing radiation (IR) is a major problem that can lead to severe injury months to years after exposure, and poses serious complications for the long-term health of radiotherapy patients. The molecular and biochemical bases of early and late IR-induced skin injury are not well understood, but our preliminary studies have shown that mitochondria-generated reactive oxygen species (ROS) contribute to IR-induced skin pathologies. Our preliminary results also suggest a role for tetrahydrobiopterin (BH4), a major cofactor in numerous enzymes and mitochondrial function, as well as in the effects on skin observed following exposure to IR. Therefore, the overall goal of the proposed project is to begin to unravel the interactive mechanisms of IR-induced changes in mitochondrial function and BH4 bioavailability. In pursuit of this goal, we will test the central hypothesis that IR induces mitochondrial ROS generation, thus impairing BH4 metabolism and increasing mitochondrial dysfunction leading to skin tissue injury through the following specific aims. In Aim 1, we will determine the role of mitochondrial ROS and its relation to BH4 metabolism during IR-induced skin toxicity. Aim 2 will elucidate the role of BH4 availability through altered expression of GTP cyclohydrolase 1 feedback regulatory protein (GFRP) in skin and mitochondrial toxicity following IR exposure. In Aim 3, we will determine whether increasing BH4 bioavailability and/or mitochondrial function via pharmacologic interventions mitigates adverse skin pathologies following IR exposure. Successful completion of these specific aims will contribute to the mechanistic understanding of the role of mitochondriagenerated ROS and BH4 metabolism during IR-induced skin injury. The knowledge to be gained holds the potential for identifying novel targets for pharmacologic manipulation for the health problems arising from IR exposures.
电离辐射(IR)引起的皮肤组织损伤是一个可能导致严重伤害的主要问题

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nukhet Aykin-Burns其他文献

Nukhet Aykin-Burns的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nukhet Aykin-Burns', 18)}}的其他基金

Sirt3: A Key Player Against PCB-Induced Mitochondrial Injury
Sirt3:对抗 PCB 引起的线粒体损伤的关键角色
  • 批准号:
    8496911
  • 财政年份:
    2013
  • 资助金额:
    $ 26.81万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了